journal article·2022-06Open access

An anti-bacterial and anti-cancer fibrous membrane with multiple therapeutic effects for prevention of pancreatic cancer recurrence

Qiang Zhang, Yang Luo, Bo Liang, Di Suo, Shang Lyu, Yi Wang, Xin Zhao

Abstract

Adjuvant systemic chemotherapy with gemcitabine (GEM) is recognized as the standard of care to improve the prognosis of patients with resected pancreatic cancer (PC); however, it is greatly limited by poor absorption of chemotherapy agents. Moreover, surgical site infection and Gammaproteobacteria-induced GEM resistance further decrease the chemotherapy efficacy and increase the risk of recurrence and even mortality. Here, we develop an implantable anti-bacterial and anti-cancer fibrous membrane (AAFM) to inhibit PC recurrence in a well-coordinated manner. Our AAFM can be readily prepared via simple co-electrospinning of GEM and poly-L-lactic acid (PLLA) and subsequent tannic acid (TA)-mediated in-situ generation of silver nanoparticles (AgNPs). The resultant membrane presents highly porous fibrous morphology and appropriate mechanical performance. Most importantly, we find the surface-deposited TA/AgNP complexes can exert multiple therapeutic effects: (1) they can act as a fence to extend GEM diffusion route, achieving a sustained drug release; (2) they can fight the pathogenic microorganisms in the local microenvironment and prevent infectious complications and alleviate Gammaproteobacteria-induced chemotherapy resistance; (3) they can combat residual cancer cells to synchronously strengthen the effectiveness of GEM-based chemotherapy. Altogether, our AAFM provides a proof-of-concept demonstration of the integrated anti-cancer and anti-bacterial strategy for enhanced therapeutic efficacy and will inspire the design of other high-performance implants for prevention of tumor relapse.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Pancreatic and Hepatic Oncology Research · Graphene and Nanomaterials Applications · Cancer Research and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (44)

Show source-provided references
2. Cancer statistics, 2020
4. Advances in drug delivery for post-surgical cancer treatment10.1016/j.biomaterials.2019.04.027 ↗
5. Plasma-activated thermosensitive biogel as an exogenous ROS carrier for post-surgical treatment of cancer10.1016/j.biomaterials.2021.121057 ↗
6. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer10.1056/NEJMoa1809775 ↗
7. Novel strategic therapeutic approaches for prevention of local recurrence of pancreatic cancer after resection: trans-tissue, sustained local drug-delivery systems10.1016/j.jconrel.2004.09.007 ↗
8. A hierarchical structured ultrafine fiber device for preventing postoperative recurrence and metastasis of breast cancer10.1002/adfm.202004851 ↗
9. Controlled drug delivery: historical perspective for the next generation10.1016/j.jconrel.2015.10.005 ↗
10. Pancreatic adenocarcinomas with mature blood vessels have better overall survival10.1038/s41598-018-37909-5 ↗
11. Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM10.1126/scitranslmed.aag2942 ↗
12. In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy10.1126/scitranslmed.aan3682 ↗
13. Prevention of lung cancer recurrence using cisplatin-loaded superhydrophobic nanofiber meshes10.1016/j.biomaterials.2015.10.060 ↗
14. Localized controlled delivery of gemcitabine via microsol electrospun fibers to prevent pancreatic cancer recurrence10.1002/adhm.201800593 ↗
15. Electrospun polymeric micro/nanofibrous scaffolds for long-term drug release and their biomedical applications10.1016/j.drudis.2017.05.007 ↗
16. Surgical site infections after pancreaticoduodenectomy: preoperative biliary system interventions and antimicrobial prophylaxis10.1016/j.ijid.2020.04.005 ↗
17. Postoperative infectious complications after pancreatic resection10.1002/bjs.9919 ↗
18. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine10.1126/science.aah5043 ↗
19. Pancreatic cancer and its microenvironment—recent advances and current controversies10.3390/ijms21093218 ↗
20. The tumor microbiome in pancreatic cancer: bacteria and beyond10.1016/j.ccell.2019.11.004 ↗
21. Fabrication of durable antibacterial and superhydrophobic textiles via in situ synthesis of silver nanoparticle on tannic acid-coated viscose textiles10.1007/s10570-018-2183-7 ↗
22. The pancreatic microbiome is associated with carcinogenesis and worse prognosis in males and smokers10.3390/cancers12092672 ↗
23. Antimicrobial susceptibility and multiplex PCR screening of AmpC genes from isolates of Enterobacter cloacae, citrobacter freundii, and Serratia marcescens10.1016/S1684-1182(10)60029-1 ↗
24. A self-sustained nanoplatform reverses TRAIL-resistance of pancreatic cancer through coactivating of exogenous and endogenous apoptotic pathway10.1016/j.biomaterials.2021.120795 ↗
25. In situ silver nanoparticle synthesis on 3D-printed polylactic acid scaffolds for biomedical applications10.1557/s43578-020-00064-7 ↗
26. The tumour microenvironment in pancreatic cancer—clinical challenges and opportunities10.1038/s41571-020-0363-5 ↗
27. Cancer-associated fibroblasts in pancreatic cancer: should they be deleted or reeducated?10.1177/1534735418794884 ↗
28. Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer10.7150/thno.53102 ↗
29. pH-sensitive nanoparticles composed solely of membrane-disruptive macromolecules for treating pancreatic cancer10.1021/acsami.0c16576 ↗
30. Distant metastasis occurs late during the genetic evolution of pancreatic cancer10.1038/nature09515 ↗
31. Pancreatic cancer associated fibroblasts (caf): under-explored target for pancreatic cancer treatment10.3390/cancers12051347 ↗
32. Facile Polyphenol–europium assembly enabled functional poly (l-lactic acid) nanofiber mats with enhanced antioxidation and angiogenesis for accelerated wound healing10.1002/adhm.202100793 ↗
33. Antibiotic irrigation during pancreatoduodenectomy to prevent infection and pancreatic fistula: a randomized controlled clinical trial10.1016/j.surg.2019.05.053 ↗
34. Tannic acid-modified silver nanoparticles for enhancing anti-biofilm activities and modulating biofilm formation10.1039/D0BM00648C ↗
35. A review on plants extract mediated synthesis of silver nanoparticles for antimicrobial applications: a green expertise10.1016/j.jare.2015.02.007 ↗
36. Green synthesis of silver nanoparticles and their applications as an alternative antibacterial and antioxidant agents10.1016/j.msec.2020.110901 ↗
37. Evaluation of the antibacterial efficacy of silver nanoparticles against enterococcus faecalis biofilm10.1016/j.joen.2013.08.022 ↗
38. Tannic acid with antiviral and antibacterial activity as a promising component of biomaterials-a minireview10.3390/ma13143224 ↗
39. In vitro antimicrobial activity of green synthesized silver nanoparticles against selected gram-negative foodborne pathogens10.3389/fmicb.2018.01555 ↗
40. Antibacterial activity and mechanism of silver nanoparticles against multidrug-resistant Pseudomonas aeruginosa10.2147/IJN.S191340 ↗
41. Molecular and cellular mechanisms of chemoresistance in pancreatic cancer10.1016/j.jbior.2017.11.007 ↗
42. The COL11A1/Akt/CREB signaling axis enables mitochondrial-mediated apoptotic evasion to promote chemoresistance in pancreatic cancer cells through modulating BAX/BCL-2 function10.7150/jca.47032 ↗
43. Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of Ki-67 immunostaining10.1007/s12022-008-9044-0 ↗
44. Caspase-3 promotes genetic instability and carcinogenesis10.1016/j.molcel.2015.03.003 ↗